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Abstract
Background
Up to 50% of hospital antibiotic use is inappropriate and therefore improvement strategies
are urgently needed. We compared the effectiveness of two strategies to improve the qual-
ity of antibiotic use in patients with a complicated urinary tract infection (UTI).
Methods
In a multicentre, cluster-randomized trial 19 Dutch hospitals (departments Internal Medicine
and Urology) were allocated to either a multi-faceted strategy including feedback, educa-
tional sessions, reminders and additional/optional improvement actions, or a competitive
feedback strategy, i.e. providing professionals with non-anonymous comparative feedback
on the department’s appropriateness of antibiotic use. Retrospective baseline- and post-
intervention measurements were performed in 2009 and 2012 in 50 patients per depart-
ment, resulting in 1,964 and 2,027 patients respectively. Principal outcome measures were
nine validated guideline-based quality indicators (QIs) that define appropriate antibiotic use
in patients with a complicated UTI, and a QI sumscore that summarizes for each patient the
appropriateness of antibiotic use.
Results
Performance scores on several individual QIs showed improvement from baseline to post-
intervention measurements, but no significant differences were found between both strate-
gies. The mean patient’s QI sum score improved significantly in both strategy groups (multi-
faceted: 61.7% to 65.0%, P = 0.04 and competitive feedback: 62.8% to 66.7%, P = 0.01).
Compliance with the strategies was suboptimal, but better compliance was associated with
more improvement.
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Conclusion
The effectiveness of both strategies was comparable and better compliance with the strate-
gies was associated with more improvement. To increase effectiveness, improvement activ-
ities should be rigorously applied, preferably by a locally initiated multidisciplinary team.
Trial Registration
Nederlands Trial Register 1742
Introduction
Complicated Urinary Tract Infections (UTIs) are among the most prevalent infectious diseases
[1,2], substantially contributing to antibiotic use in the hospital setting. According to medical
literature, up to 50% of hospital antibiotic use is inappropriate [3–5]. Inappropriate antibiotic
use has been associated with an increase in morbidity, mortality, length of stay, hospital costs
and raising bacterial resistance [6–10]. In a previous study, we defined appropriate antibiotic
use for patients with a complicated UTI with a valid set of nine guideline-based quality indica-
tors (QIs) (Table 1) and showed in a pilot study large room for improvement on most QIs [11].
To improve appropriate antibiotic use, Antimicrobial Stewardship Programs (ASPs) are
propagated [12], which can be considered as ‘a menu of interventions that can be designed and
adapted to fit the infrastructure of any hospital’ [13]. This menu suggests various improvement
interventions of which it has been shown that they effectively improve antibiotic prescribing in
hospitals [3]. Unfortunately, direct comparisons of the effectiveness of these different improve-
ment interventions in a methodological powerful design are scarce [3–14]. Such head-to-head
comparisons, for which a cluster-randomized trial design is considered to be the ideal [3], are
urgently needed to extend the current evidence for effectively improving antibiotic prescribing
[3,15].
Therefore, we conducted a cluster-randomized trial of two interventions, or strategies, to
improve antibiotic use in patients with a complicated UTI. We aimed to assess the effectiveness,
Table 1. Set of Quality Indicators [11].
Quality indicators
1 Perform a urine culture
2 Prescribe empirical therapy in accordance with the national guideline
3 Switch from intravenous to oral therapy within 72 h on the basis of the clinical condition
4 Tailor antibiotic treatment on the basis of culture results
5 Use ﬂuoroquinolones selectively (oral therapy, or in case of anaphylaxis to beta-lactam antibiotics)
6 Duration of antibiotic therapy should be at least 10 days (in accordance with the national guideline)
7* Treat UTI in men in accordance with the national guideline
8 Replace urinary catheter after initiation of antibiotic treatment
9 Adapt antibiotic dose according to renal function
* Additional QI for men with a UTI. This QI applies to (denominator) men with a UTI, including those with a
chronic prostatitis. It evaluates (numerator) whether they were treated in accordance with the guideline
regarding empirical therapy and treatment duration and, in case of chronic prostatitis, whether they were
treated with culture-guided therapy for the recommended duration.
doi:10.1371/journal.pone.0142672.t001
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measured as the before-and-after-intervention performance on the QIs, of two improvement
strategies: 1) a Multi-Faceted Strategy, comparable to an effective strategy to improve antibiotic
use in patients with lower respiratory tract infections [16] and 2) a ‘Competitive Feedback Strat-
egy’, i.e. providing professionals with non-anonymous comparative feedback on the depart-
ment’s appropriateness of antibiotic use in patients with complicated UTIs. Additionally, we
aimed to identify determinants of successful improvement.
Methods
Design and setting
We conducted a multicentre, cluster-randomized trial to compare the effectiveness of two dif-
ferent strategies to improve the appropriateness of antibiotic use in patients with a complicated
UTI (QUality of ANtibiotic use in uTI patients (QUANTI) trial, http://www.trialregister.nl;
NTR 1742).
Between February and November 2009 a retrospective baseline measurement was per-
formed at the Internal Medicine and Urology departments of 19 university and non-university
hospitals located throughout the Netherlands. By February 2010, hospitals were randomly allo-
cated to one of the improvement strategies. Between April 15 and October 15, 2010, in each
hospital the allocated improvement strategy was implemented. From six months later patients
were included in a post-intervention measurement (exact starting point differed by hospital,
see Fig 1b). For both the baseline and post-intervention measurement the minimal sample
size was 50 patients per department. Enrolment of this number of patients took on average,
depending on the department, 1.5 years, so (retrospective) post-intervention measurement
could not start before April 2012.
The medical ethical committee of the Academic Medical Centre Amsterdam considered our
study and concluded that it was deemed exempt from their approval (ref 08.17.1775). No
informed consent was obtained from patients because no interventions at the patient level were
done and patient data were analysed in a retrospective design anonymously, for the aim to
improve quality or healthcare.
Informed consent was obtained from the contact persons of the participating hospitals.
Patient selection
From the hospital diagnosis registration system patients were screened for nationally defined
categories: cystitis, pyelonephritis, prostatitis and bacteremia. Included were adults ( 16
years) who were referred to the hospital (inpatient/outpatient clinic) and diagnosed by an
internist or urologist with a complicated UTI (including catheter-associated UTIs) as main
diagnosis and treated as such. We defined a complicated UTI as a UTI with one of the follow-
ing characteristics: male gender, pregnancy, any functional or anatomical abnormality of the
urinary tract, immunocompromising disease or medication, or a UTI with symptoms of tissue
invasion or systemic infection (pyelonephritis, urosepsis, prostatitis) [17].
Multi-faceted strategy (MFS)
This strategy was comparable to an improvement strategy developed by Schouten et al. [16]
that effectively improved antibiotic use in patients with lower respiratory tract infections in a
cluster-randomized trial in six Dutch hospitals. Their strategy contained standardized elements
that were used in all hospitals and additional interventions that were locally adjusted to the
needs and wishes of that specific hospital. The antibiotic use QIs that were most in need of
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Fig 1. Flow charts of study design and participants; MFS = Multi-Faceted Strategy, CFS = Competitive Feedback Strategy. * CFS: patients enrolled
from October 15, 2010: enrolment in post-intervention measurement at least 6 months after providing the feedback reports. MFS: patient enrolment in post-
intervention measurement depended on the individual implementation schedule: at least 3 months after the hospital’s kick-off meeting, and at least 6 months
after providing the first feedback report.
doi:10.1371/journal.pone.0142672.g001
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improvement were given priority. All interventions were initiated and coordinated by the
researcher and a project quality improvement officer.
Our MFS consisted of comparable standardized elements, but more strongly involved local
professionals in the design and performance of the locally tailored interventions. The interven-
tion consisted of three separate phases (see Figs 2 and 3).
Competitive feedback strategy (CFS)
In this era of transparency, it is becoming increasingly common to release performance data–
either individually or publicly–with the aim of improving healthcare performance [18]. Indi-
vidual audit and feedback is widely used to improve practice by giving professionals insight
into their own performance [15]. Simultaneously, performance data are released into the public
domain (i.e. public reporting), aiming to improve quality by ranking performance of different
providers [19–21]. We combined the best of these two approaches, by providing individual
feedback to the professionals by non-anonymously ranking the various departments. In this
manner we aimed to include the competitive element of public reporting in the individual feed-
back strategy, resulting in a so-called competitive feedback strategy.
Competitive feedback reports contained, for each QI, a list of all 38 departments’ perfor-
mance scores, in which the names of the MFS departments were blinded, but the others were
visible. For reasons of confidentiality, feedback reports were sent by regular mail and receipt of
the reports was verified.
Variables and data collection
Effect parameters: Quality indicators for appropriate antibiotic use. The appropriate-
ness of antibiotic use was scored using QIs which are based on the treatment recommendations
from the Dutch national, evidence-based guideline for the antimicrobial treatment of compli-
cated UTIs [22]. In an earlier study, a 3-step modified RAND Delphi approach among experts
was used to systematically develop a set of nine QIs, which was subsequently validated [11]
(Table 1). All QIs are dichotomous variables, distinguishing appropriate from inappropriate
antibiotic use in each individual patient. Data were collected by retrospective chart review by
the study researcher together with one (baseline) or two (post-intervention) trained research
assistants. The assistants were blinded for the strategy status of the hospitals. QI performance
was calculated for each patient using previously constructed algorithms [10].
To summarize patients’ performance on the different QIs in one outcome measure, we cal-
culated − at baseline- and post-intervention measurement − for each patient a total QI set per-
formance, defined as the patient’s QI sumscore divided by the number of QIs that applied to
that specific patient [10].
Determinants of improvement. We aimed to identify determinants of successful improve-
ment, because insight into the mechanisms responsible for the results could enhance the validity
of the findings and might help to understand the potential generalizability of the strategies [23–
24]. We examined whether the following variables were associated with improved total QI set
performance: compliance with the strategies, department’s baseline performance on the total QI
set, inpatient versus outpatient and Internal Medicine versus Urology.
Compliance with improvement strategies: To measure compliance with the various ele-
ments of the improvement strategies, we assessed for all departments which improvement
activities were actually performed, e.g. whether feedback reports and the improvement plan
were disseminated and/or presented by the local contact person and whether/what additional
improvement actions were carried out. Compliance data were collected using a questionnaire
filled in by the contact persons (February 2011). The attendance of local professionals at the
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kick-off meetings was registered by the study researcher. A sum score was calculated reflecting
the compliance per department (Fig 3).
Department’s baseline performance on the total QI set: For each department, a baseline
performance score was assessed by calculating the mean total QI set performance of all patients
of that department during the baseline measurement.
Sample size
We anticipated a difference between the two strategies in QI adherence of 15% in favour of the
MFS after the intervention (70% versus 55%). Intraclass correlations (ICC) calculated in our
Fig 2. Description of standardized (bold) and optional (italic) elements of the multi-faceted strategy (MFS) [30–33].
doi:10.1371/journal.pone.0142672.g002
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QI development study [11] for three of our QIs showed a mean ICC of 0.10. Using alpha =
0.05, two-sided testing, power = 0.80 and ICC = 0.10, we needed 18 clusters of 250 individuals
per strategy if only one indicator was measured per individual. Since we measured more indica-
tors per individual, and assuming a correlation of 0.5 between the indicator values from the
same individual, the number of individuals per cluster could be reduced by a factor five, requir-
ing a sample size of 18 clusters of 50 patients each per strategy. The total number of patients
that should be included for the trial was 3600 patients (18 (clusters)  50 (patients)  2 (strate-
gies)  2 (baseline- and post-intervention measurement)).
Statistical analysis
Randomization of the hospitals was balanced by minimization on hospital’s baseline individual
QI performance scores and was performed by a statistician who was blinded to the composi-
tion of the groups.
As descriptive statistics, we give the percentage appropriate antibiotic use per QI, and
means for total QI set performance. Not every QI was applicable to all included patients,
Fig 3. Activities and compliance scores per strategy; MFS = Multi-Faceted Strategy, CFS = Competitive Feedback Strategy. Elements in bold are
standardized strategy elements; elements in italics are optional. LOC: Local Organizing Committee. *more than the median score of all departments.
doi:10.1371/journal.pone.0142672.g003
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therefore the sample sizes of the QIs varied. For a QI to be included in the analyses, we
decided that the minimum sample size was a mean of 15 patients per department in the base-
line measurement.
The effectiveness of the strategies on the individual QIs was assessed by multilevel logistic
regression analysis, with clusters determined by the unique hospital-department combinations.
We allowed the improvement from baseline to post-intervention measurement to differ by
strategy. In an adjusted analysis we controlled for the patient characteristics gender, age, uro-
logical comorbidity, diabetes and being in- or outpatient.
To test the effectiveness of the strategies on the total QI set performance, multilevel linear
regression analysis was performed, in which the residual variance was weighted for the number
of QIs that applied to the individual patient. Hence, we assumed a normal distribution of the
total QI set performance. Although this is not correct for the individual total QI values, its dis-
turbing effect on the parameter estimates may be reduced due to the large sample size. As an
alternative, we performed a logistic regression analysis in which all individual QIs were
included. In this model, we assumed that the average value was equal for every QI and that
there was no correlation between QI performance scores within a patient.
We also used multilevel linear regression analysis to test for each strategy the association
between possible determinants of successful improvement (compliance with strategies, depart-
ment’s baseline total QI set performance, inpatient/outpatient, Internal Medicine/Urology)
and the total QI set performance. For the effect of baseline performance, we regressed the indi-
vidual post-intervention total QI set performance on the mean value per department at base-
line. We performed the analyses using R version 3.0.1 and the lme4 package [25,26]. A value of
P< 0.05 was considered statistically significant.
Results
Study population
The baseline population consisted of 1,964 patients, the post-intervention population of 2,027
patients (Fig 1b). Their characteristics are described in Table 2. Of the 19 included hospitals 4
were university hospitals, of which 3 were randomized to the CFS group and 1 to the MFS
group.
Effectiveness of strategies
Table 3 shows for each strategy the baseline (T0) and post-intervention (T1) performance on
the individual QIs and total QI set performance. Three QIs did not reach the minimum sample
size to be included in the analyses, because they were not applicable in enough patients: ‘Use
fluoroquinolones selectively’, ‘Replace catheter after initiation of treatment’, and ‘Adapt antibi-
otic dose according to renal function’.
For the total sample, several performance scores on the individual QIs showed improvement
from baseline to post-intervention measurements. Performing a urine culture increased in
both strategy groups (MFS: 72.6% to 80%, P = 0.01 and CFS: 76.9% to 83.5%, P = 0.008). Tai-
loring antibiotic treatment on the basis of culture results (74.1% to 80.9%, P = 0.03) and treat-
ing UTI in men in accordance with the national guideline (33.2% to 38.3%, P = 0.05) improved
significantly in the CFS group. No significant differences were found between both strategies in
the improvement of individual QI scores (Table 3). Correcting for gender, age, urological
comorbidity, diabetes and inpatient/outpatient did not significantly change these results.
The total QI set performance improved significantly in both strategy groups (Table 3), but
the difference between the strategies was not statistically significant, neither in the multilevel
linear regression analysis nor in the logistic analysis (see Methods).
Improving Antibiotic Use in UTI Patients
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Determinants of improvement
Compliance with improvement strategies. In the MFS group, the first feedback report
was disseminated and presented in 33% (6/18) of departments, it was either disseminated or
presented in 44% (8/18) and it was neither disseminated nor presented in 22% (4/18). For the
Table 2. Patient characteristics at baseline and post-intervention; MFS = Multi-Faceted Strategy, CFS = Competitive Feedback Strategy.
Baseline population (T0) Post-intervention population (T1)
MFS (n = 923) CFS (n = 1041) MFS (n = 963) CFS (n = 1064)
Men, n (%) 538 (58.3) 596 (57.3) 562 (58.4) 651 (61.2)
Age, years (mean; SD) 61.7 (20.1) 61.4 (20.0) 62.9 (19.4) 63.7 (17.7)
Urological comorbidity, n (%) 179 (19.4) 227 (21.8) 206 (21.4) 204 (19.2)
Diabetes, n (%) 196 (21.2) 185 (17.8) 230 (23.9) 205 (19.3)
Urinary catheter, n (%) 129 (14.0) 143 (13.7) 149 (15.5) 156 (14.7)
Outpatient, n (%) 337 (36.5) 313 (30.1) 357 (37.1) 404 (38.0)
Internal Medicine, n (%) 460 (49.8) 521 (50.0) 484 (50.3) 541 (50.8)
For all characteristics: missing data in < 3 patients.
doi:10.1371/journal.pone.0142672.t002
Table 3. Performance on quality indicators before (T0) and after intervention (T1).
Quality indicator Multi-faceted strategy a Competitive feedback
strategy a
Odds ratio (95% CI) b P b
T0 T1 T1-T0 T0 T1 T1-T0
n = 923 n = 963 P b n = 1041 n = 1064 P b
1 Perform a urine culture, n 669/922 769/961 800/1040 888/1064
% 72.6 80.0 + 7.4 76.9 83.5 + 6.6 0.99 0.98
P 0.01 0.008 (0.64;1.55)
2 Prescribe according to national guideline, n 447/679 450/670 531/786 498/703
% 65.8 67.2 + 1.4 67.6 70.8 + 3.2 0.89 0.59
P 0.83 0.32 (0.59;1.35)
3 Switch from i.v. to oral therapy within 72 hours, n 127/243 124/251 177/317 170/282
% 52.3 49.4 - 2.9 55.8 60.3 + 4.5 0.68 0.31
P 0.47 0.48 (0.32;1.44)
4 Tailor antibiotic treatment based on culture result, n 390/513 438/549 480/648 535/661
% 76.0 79.8 + 3.8 74.1 80.9 + 6.8 0.81 0.36
P 0.46 0.03 (0.51;1.28)
6 Treatment duration should be at least 10 days, n 396/720 418/761 444/833 469/882
% 55.0 54.9 - 0.1 53.3 53.2 - 0.1 1.04 0.86
P 0.78 0.97 (0.71;1.51)
7 Treat UTI in men according to national guideline, n 156/434 172/441 160/482 202/527
% 35.9 39.0 + 3.1 33.2 38.3 + 5.1 0.90 0.62
P 0.23 0.047 (0.61;1.34)
Total QI set performance (%) c; mean of all patients 61.7 65.0 +3.3 62.8 66.7 + 3.9 0.77
P 0.043 0.010
a Missing data in < 10 patients; numbers in bold indicate a signiﬁcant change in QI performance.
b Odds ratios (ORs) for difference between strategies and P-values were adjusted in a multilevel analysis for clustering of patients in departments and
hospitals. Data are not adjusted for baseline characteristics.
c Proportion of appropriately performed QIs per patient (QI sumscore divided by number of applicable QIs).
doi:10.1371/journal.pone.0142672.t003
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improvement plan, dissemination and presentation occurred in 28% (5/18), dissemination or
presentation in 44% (8/18) and none of them in 28% (5/18). For the second feedback report
these percentages were 11%, 27% and 62%, respectively. Additional LOC meetings were orga-
nized in 28% (5/18) and pocket cards were distributed in 56% (10/18) of departments. Addi-
tional improvement actions were performed in 39% (7/18) of departments (S1 Table). The
maximum compliance sum score (Fig 3) was 12, with a median of 4. Fig 4a demonstrates a
non-significant association between compliance to the MFS and the total QI set improvement
(P = 0.095).
In the CFS group, the first feedback report was disseminated and presented in 30% (6/20) of
departments, it was disseminated or presented in 40% (8/20) and in 30% (6/20) it was neither
disseminated nor presented. Additional improvement actions were performed in 40% (8/20) of
departments (S1 Table). The maximum compliance sum score (Fig 3) was 6, with a median of
1. Fig 4b shows that better compliance to the CFS was significantly associated with total QI set
improvement (P = 0.04).
Department’s baseline performance on the total QI set. For both strategies, a lower
department's mean baseline performance on the total QI set was associated with more total QI
set improvement. For both strategies, total QI set performance significantly improved at
departments with a mean baseline total QI set performance60% (Fig 5a+b).
Inpatients versus outpatients. Improvement on the total QI set performance was compa-
rable for inpatients and outpatients in both strategies (MFS: P = 0.81, CFS: P = 0.21) (Table 4).
Fig 4. Improvement of the total QI set performance in relation to department’s compliance with improvement strategies.Difference in performance
between T1 and T0, 95% CIs are shaded.
doi:10.1371/journal.pone.0142672.g004
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Internal medicine versus urology. In both strategies, improvement on the total QI set
performance did not differ significantly between patients treated at Internal Medicine or Urol-
ogy departments (MFS: P = 0.34, CFS: P = 0.21) (Table 4).
Discussion
In this study, we compared the effectiveness of two strategies to improve antibiotic use in
patients with a complicated UTI. We found that performance scores on several individual QIs
Fig 5. Improvement of the total QI set performance in relation to department’s mean baseline performance on the total QI set. Difference in
performance between T1 and T0, 95% CIs are shaded. Dots indicate individual department’s score.
doi:10.1371/journal.pone.0142672.g005
Table 4. Possible determinants of successful improvement.
Determinants MFS, Total QI set performancea, b %; mean of all
patients
P c CFS, Total QI set performancea, b %; mean of all
patients
P c
T0 (n = 923) T1 (n = 963) T1-T0, change (95%CI) T0 (n = 1041) T1 (n = 1064) T1-T0, change (95%CI)
Inpatient/ outpatient
Inpatient 65.5 (n = 586) 69.1 (n = 605) +3.6 (-0.29;7.37) 0.81 65.4 (n = 728) 71.3 (n = 660) +5.9 (2.70;9.13) 0.21
Outpatient 54.2 (n = 337) 57.0 (n = 357) +2.8 (-2.34;7.99) 55.9 (n = 313) 58.4 (n = 404) +2.5 (-2.11;7.20)
Department
Internal Medicine 65.5 (n = 460) 67.2 (n = 484) +1.7 (-2.79;6.28) 0.34 67.2 (n = 521) 72.8 (n = 541) +5.6 (1.66;9.55) 0.21
Urology 57.9 (n = 463) 62.8 (n = 479) +4.9 (0.20;9.70) 58.4 (n = 520) 60.4 (n = 523) +2.0 (-2.12;6.11)
a Missing data in 1 patient (being inpatient or outpatient).
b Proportion of appropriately performed QIs per patient (QI sumscore divided by number of applicable QIs).
c P-values for difference in trend between both subgroup.
doi:10.1371/journal.pone.0142672.t004
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showed improvement from baseline to post-intervention measurements, but no systematic dif-
ferences between both strategies were found. The total QI set performance improved statisti-
cally significantly in both strategy groups. Better compliance with the strategies was associated
with more improvement on the total set of QIs. Low department’s baseline performance on the
total set of QIs was associated with a larger effect of both improvement strategies.
In our study, the multi-faceted strategy was less effective than the original strategy by
Schouten et al., which was developed to improve antibiotic use in patients with lower respira-
tory tract infections [16]. A possible explanation for this difference might be that in our strat-
egy, after effectuating the standardized intervention elements, performance of the optional and
additional improvement activities strongly depended on local professionals, whereas in the
original strategy the study researcher and project quality improvement officer actively initiated
and coordinated these flexible activities. We considered involvement of local professionals to
be a crucial element of our strategy, as this showed to be successful in achieving sustainable
improvement [3,27] and in general contributes to the local performance of improvement strat-
egies. However, we probably overestimated the persuasive power of our strategy to involve
local professionals. In this light, evaluation of departments’ compliance with the strategy was
relevant [24], as it confirmed suboptimal compliance at many departments, and a trend
towards more improvement with better compliance. Our results suggest that for improvement
strategies initiated from outside the hospital it is difficult to actually engage professionals from
the ‘inside’, resulting in less effectiveness of the strategy. This emphasizes the need for a locally
initiated multidisciplinary team, as recommended in the development of antimicrobial stew-
ardship programs [12].
Concerning the competitive feedback strategy, better compliance with the strategy was sig-
nificantly related to more improvement. This relation was stronger than for the MFS. Our
compliance evaluation showed that feedback reports were disseminated and/or presented often
and additional improvement actions were performed in 40% of departments. This is in contrast
with literature suggesting that physicians are sceptical about public data and consider them of
minimal use [21,28,29]. In addition, there is no consistent evidence that the public release of
performance data improves care [20]. Possibly, our CFS found the appropriate balance between
being a stimulus by creating accountability [20] and ensuring enough confidentiality.
Besides compliance with the various elements of the improvement strategies, other variables
turned out to be determinants of successful improvement. A low department’s baseline total
QI set performance seemed to be associated with a larger effect of both improvement strategies,
which is in line with previous studies on improving professional practice [15,23]. However,
regression to the mean effects may be partially responsible for these trends.
Furthermore, subgroup analyses showed that for inpatients and outpatients and for the dif-
ferent departments (Internal Medicine or Urology) the size of improvement was comparable.
The major strength of our study is the large study sample including hospitals from all over
the Netherlands and the large patient populations, as required by a cluster-randomized trial
with different intervention arms. Second, the design of the study and the collection of data
regarding multiple aspects of care that were derived from the medical records of each individ-
ual patient contribute to the validity of our results. Finally, we not only assessed effectiveness of
two strategies, but also provided insight into what variables determine effectiveness. Future
improvement studies can build on this insight.
Our study has a few limitations. First, no control group was included, because the major
goal was to compare two improvement strategies. Consequently, differences between baseline
to post-intervention measurements might be (partially) explained by the Hawthorne effect,
where behaviour changes as a result of being under study. However, two recently updated
Cochrane reviews state that head-to-head intervention trials are urgently needed [3,15].
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Second, we summarized compliance in a sum score, adding all activities together, without tak-
ing into account the more detailed content of them. Nevertheless, we demonstrated a positive
relationship between better compliance scores and total QI set performance improvement. We
earlier demonstrated that better performance on the total set of QIs as such was associated
with a shorter length of hospital stay [10].
In conclusion, our results are relevant because they reflect the difficulties in daily practice
when introducing–nowadays popular- public reporting strategies or multi-faceted stewardship
programs. We think that these improvement strategies and programs should be developed
and carried out by a locally initiated multidisciplinary team to improve effectiveness. Equally
important, our study shows that the effectiveness of an intervention strategy increases when it
is more rigorously applied: a comprehensive set of interventions ultimately results in more
improvement. Finally, we introduced a competitive feedback strategy that appeared to be less
time-consuming and equally effective in improving QI performance scores, compared to a
multi-faceted strategy. This competitive feedback strategy should be tested in a broader setting.
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